Longwood Fund
North America, Massachusetts, United States, Boston
Description
Longwood Fund finances science-based companies that develop novel solutions for medical problems.
Investor Profile
Longwood Fund has made 62 investments, with 6 in the past 12 months and 18% as lead.
Stage Focus
- Series A (42%)
- Series B (26%)
- Series C (18%)
- Series Unknown (10%)
- Series D (2%)
- Seed (2%)
- Private Equity (2%)
Country Focus
- United States (89%)
- United Kingdom (10%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- Italy (2%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Pharmaceutical
- Life Science
- Medical
- Biopharma
- Oncology
- Medical Device
- Health Diagnostics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
